Wade Walke | Vice President of Investor Relations |
Anne Wojcicki | Co-Founder and Chief Executive Officer |
Kenneth Hillan | Chief Therapeutics Officer |
Steve Schoch | Chief Financial Officer |
Tiago Fauth | Credit Suisse AG |
Daniel Grosslight | Citigroup Inc. |
Good morning, and welcome to the 23andMe's Fiscal Year 2022 Fourth Quarter and Year-End Financial Results Conference Call.
As a reminder, this call is being recorded. At this time, all participants are in a listen-only mode. After the prepared remarks, there will be a question-and-answer session. I would now like to turn the call over to Wade Walke, Vice President of Investor Relations to lead off the call.